Technology News and Research

RSS

Seaside Therapeutics commences STX107 Phase 1 clinical trial for Fragile X Syndrome

Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism.

3 Nov 2009

mPhase Technologies receives U.S. patent for "greener" battery technology

mPhase Technologies, Inc. reported today that it has been granted a United States patent for its concept for a battery that is safer for the environment. mPhase's "greener" battery technology could potentially help to reduce the harmful residual chemicals in a battery once it has reached the end of its life and is discarded.

3 Nov 2009

Siemens Healthcare to distribute Candelis' ImageGrid PACS-RT Appliance and ImageGrid RT Viewer

Today, Candelis, Inc. announced its plans to distribute and sell the ImageGrid™ PACS-RT Appliance and the ImageGrid™ RT Viewer through Siemens Healthcare’s Oncology Care Systems Business Unit.

3 Nov 2009

Modified version of Bluetooth can transfer patient data four times as fast as conventional Bluetooth

A telemedicine system based on a modified version of the Bluetooth wireless protocol can transfer patient data, such as medical images from patient to the healthcare provider's mobile device for patient assessment almost four times as fast as conventional Bluetooth and without the intermittent connectivity problems, according to a paper in the forthcoming issue of the International Journal of Medical Engineering and Informatics.

3 Nov 2009

Caliper Life Sciences to use SRU Biosystems’ label-free BIND technology for new functional assays

SRU Biosystems today announced that Caliper Life Sciences will use SRU Biosystems’ label-free BIND® technology to offer new functional assays as part of its Discovery Alliances and Services.

3 Nov 2009

Phase 1 study of STX107 for Fragile X syndrome begins

NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability. There has to date been no medication that could alter the disorder's neurologic abnormalities. The study will evaluate safety, tolerability, and optimal dosage in healthy volunteers.

3 Nov 2009

Mechanical force switches T cell from disease-scanning to disease-fighting mode

The immune system's T cells have the unique responsibilities of being both jury and executioner. They examine other cells for signs of disease, including cancers or infections, and, if such evidence is found, rid them from the body. Precisely how T cells shift so swiftly from one role to another, however, has been a mystery.

3 Nov 2009

U.S. PTO grants third patent for Kane Biotech's Competence Stimulating Peptide technology

Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, is pleased to announce the issuance of Patent No. 7,597,895 entitled "Signal peptides, nucleic acid molecules and methods for treatment of caries" by the U.S. Patent and Trademark Office. This is the third patent to issue protecting Kane Biotech's CSP (Competence Stimulating Peptide) technology.

3 Nov 2009

NuPathe and SurModics sign a drug delivery technology license agreement

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc., a neuroscience-focused specialty pharmaceutical company, announced today that the companies have entered into a license agreement for drug delivery technology.

3 Nov 2009

CareTech Solutions signs agreement to acquire IGCN

CareTech Solutions, Inc. (www.caretechsolutions.com) announced today the firm has reached agreement in principle to acquire IGCN (www.IGCN.com). CareTech Solutions is an information technology and web products and services provider for hospitals and health systems and IGCN provides solutions for hospitals to build and manage robust websites.

3 Nov 2009

GICD, Stanford University collaborate to develop stem cell and regenerative medicine therapies

Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine therapies. GICD investigators, led by GICD Director Deepak Srivastava, MD, will collaborate with a Stanford team led by Robert Robbins, MD, professor and chair of cardiothoracic surgery, to investigate how to use induced pluripotent stem cells, or iPS cells, to repair damaged heart muscle.

3 Nov 2009

Cardium Therapeutics to seek FDA marketing clearance for ExcellagenXL

Cardium Therapeutics today announced plans to submit a 510(k) premarket notification with the U.S. Food and Drug Administration (FDA) seeking marketing clearance of its ExcellagenXL(TM) product candidate.

3 Nov 2009

Cambridge Research & Instrumentation launches inForm image analysis software

Cambridge Research & Instrumentation, Inc. (CRi), a leader in biomedical imaging, today announced the launch of inForm™, advanced image analysis software based on the company’s proprietary Machine Learning System (MLS). inForm solves biologists’ and cancer researchers’ challenging image analysis problems by combining fast and easy-to-use automated image processing with advanced learning features that enable the user to train the software to process images automatically.

3 Nov 2009

Aetna inks three-year agreement with HHC

Aetna announced today that it has reached an agreement with the New York City Health and Hospitals Corporation (HHC) to offer Aetna members in New York City in-network access to in-patient and out-patient services from HHC’s 11 acute care hospitals, six Diagnostic and Treatment Centers and four nursing homes.

2 Nov 2009

BioVex publishes OncoVEX (GM-CSF) Phase 2 study results

BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from its completed Phase 2 clinical study of OncoVEX (GM-CSF) for the treatment of advanced melanoma has been published in the Journal of Clinical Oncology (JCO). The previously announced top line results report a high objective durable response rate and a high complete response rate, combined with a relatively benign side effect profile.

2 Nov 2009

superDimension launches the iLogic electromagnetic navigation bronchoscopy tool

superDimension, Inc.®, a private company that develops minimally invasive interventional pulmonology devices, announced today the launch of the iLogic System for early lung cancer detection and diagnosis. The device is the second generation version of inReach(TM), superDimension's electromagnetic navigation bronchoscopy (ENB) minimally invasive tool.

2 Nov 2009

Blue Cross Blue Shield of Michigan, OPR launch an innovative oncology treatment initiative

Blue Cross Blue Shield of Michigan and Oncology Physician Resource announced today the launch of an innovative oncology treatment initiative aimed at enhancing the quality of care for patients with certain types of cancer.

2 Nov 2009

Atrial fibrillation device market will grow by almost 10% through 2013: MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the atrial fibrillation device market will grow by almost 10% through 2013 in the US, Europe, and Japan. MRG's Global Markets for Atrial Fibrillation Devices 2009 report finds that many patients will be treated with electrophysiology technology and related devices as positive clinical results supporting their use emerges.

2 Nov 2009

ISB and Complete Genomics embark on the largest complete human genome disease association study

The Institute for Systems Biology (ISB) and Complete Genomics Inc. announced today that they are embarking on a large-scale human genome sequencing study of Huntington’s disease (HD). ISB has engaged Complete Genomics to sequence 100 genomes, the majority of which will be used to investigate this disease, with samples from affected individuals, family members, and matched controls to study modifiers of disease presentation and progression.

2 Nov 2009

AllOne Health partners with Connectyx Technologies Holdings to provide health information on the Web

AllOne Health(SM) and Connectyx Technologies Holdings Group, Inc. (Pink Sheets: CTYX) today announced a partnership that will allow consumers to view and manage health information on the Web, via portable USB storage devices and through their mobile phones, with one, secure step. A package including both companies' products will be sold in retail stores across the U.S. in December.

2 Nov 2009

Technology News and Research

Seaside Therapeutics commences STX107 Phase 1 clinical trial for Fragile X Syndrome

mPhase Technologies receives U.S. patent for "greener" battery technology

Siemens Healthcare to distribute Candelis' ImageGrid PACS-RT Appliance and ImageGrid RT Viewer

Modified version of Bluetooth can transfer patient data four times as fast as conventional Bluetooth

Caliper Life Sciences to use SRU Biosystems’ label-free BIND technology for new functional assays

Phase 1 study of STX107 for Fragile X syndrome begins

Mechanical force switches T cell from disease-scanning to disease-fighting mode

U.S. PTO grants third patent for Kane Biotech's Competence Stimulating Peptide technology

NuPathe and SurModics sign a drug delivery technology license agreement

CareTech Solutions signs agreement to acquire IGCN

GICD, Stanford University collaborate to develop stem cell and regenerative medicine therapies

Cardium Therapeutics to seek FDA marketing clearance for ExcellagenXL

Cambridge Research & Instrumentation launches inForm image analysis software

Aetna inks three-year agreement with HHC

BioVex publishes OncoVEX (GM-CSF) Phase 2 study results

superDimension launches the iLogic electromagnetic navigation bronchoscopy tool

Blue Cross Blue Shield of Michigan, OPR launch an innovative oncology treatment initiative

Atrial fibrillation device market will grow by almost 10% through 2013: MRG

ISB and Complete Genomics embark on the largest complete human genome disease association study

AllOne Health partners with Connectyx Technologies Holdings to provide health information on the Web

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News